AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
132.86B
VIAAX
Price
$43.61
Change
+$0.15 (+0.35%)
Updated
Sep 5 closing price
Net Assets
8.88B
Interact to see
Advertisement

AEPCX vs VIAAX

Header iconAEPCX vs VIAAX Comparison
Open Charts AEPCX vs VIAAXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets132.86B
Vanguard Intl Div Apprec Idx Adm
Price$43.61
Change+$0.15 (+0.35%)
VolumeN/A
Net Assets8.88B
AEPCX vs VIAAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. VIAAX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and VIAAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. VIAAX (8.88B). VIAAX pays higher dividends than AEPCX: VIAAX (1.81) vs AEPCX (0.16). AEPCX was incepted earlier than VIAAX: AEPCX (25 years) vs VIAAX (10 years). AEPCX (1.57) is less costly to investors than VIAAX (0.16). AEPCX is a more actively managed with annual turnover of: 35.00 vs. VIAAX (18.00). AEPCX has a lower initial minimum investment than VIAAX: AEPCX (250) vs VIAAX (3000). AEPCX annual gain was more profitable for investors over the last year : 7.59 vs. VIAAX (3.95). VIAAX return over 5 years is better than : 26.30 vs. AEPCX (7.78).
AEPCXVIAAXAEPCX / VIAAX
Total Expense Ratio1.570.16981%
Annual Report Gross Expense Ratio1.570.16981%
Fund Existence25 years10 years-
Gain YTD15.03812.311122%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets133B8.88B1,498%
Annual Yield % from dividends0.161.819%
Returns for 1 year7.593.95192%
Returns for 3 years32.6536.4490%
Returns for 5 years7.7826.3030%
Returns for 10 years34.34N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.270.03
+2.42%
Pacific Biosciences of California
VVX56.681.23
+2.22%
V2X
GANX1.760.02
+1.15%
Gain Therapeutics
LINE40.590.13
+0.32%
Lineage Inc.
QVCGP6.980.02
+0.29%
QVC Group Inc.